Liabilities and Equity of IMMUCELL CORP /DE/ from 31 Dec 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
IMMUCELL CORP /DE/ quarterly Liabilities and Equity in USD history and change rate from 31 Dec 2010 to 30 Sep 2025.
  • IMMUCELL CORP /DE/ Liabilities and Equity for the quarter ending 30 Sep 2025 was $45,730,123, a 2.9% increase year-over-year.
Source SEC data
View on sec.gov
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Change (%)

IMMUCELL CORP /DE/ Quarterly Liabilities and Equity (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $45,730,123 +$1,281,250 +2.9% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $46,720,898 +$4,865,440 +12% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $45,621,579 +$2,570,531 +6% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $45,100,477 +$1,292,375 +3% 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 $44,448,873 -$96,149 -0.22% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 $41,855,458 -$2,151,610 -4.9% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $43,051,048 -$72,139 -0.17% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 $43,808,102 -$1,052,547 -2.3% 31 Dec 2023 10-K 28 Mar 2025 2024 FY
Q3 2023 $44,545,022 -$1,856,539 -4% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $44,007,068 -$1,976,781 -4.3% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $43,123,187 -$3,576,309 -7.7% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $44,860,649 +$394,961 +0.89% 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q3 2022 $46,401,561 +$2,170,098 +4.9% 30 Sep 2022 10-Q 21 Nov 2022 2022 Q3
Q2 2022 $45,983,849 +$2,254,206 +5.2% 30 Jun 2022 10-Q/A 21 Nov 2022 2022 Q2
Q1 2022 $46,699,496 +$7,078,034 +18% 31 Mar 2022 10-Q/A 21 Nov 2022 2022 Q1
Q4 2021 $44,465,688 +$4,116,094 +10% 31 Dec 2021 10-K 29 Mar 2023 2022 FY
Q3 2021 $44,231,463 +$4,244,255 +11% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 $43,729,643 +$3,069,061 +7.5% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $39,621,462 -$432,812 -1.1% 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 $40,349,594 +$1,657,758 +4.3% 31 Dec 2020 10-K 30 Mar 2022 2021 FY
Q3 2020 $39,987,208 +$1,139,600 +2.9% 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 $40,660,582 +$1,251,184 +3.2% 30 Jun 2020 10-Q 12 Aug 2020 2020 Q2
Q1 2020 $40,054,274 -$422,356 -1% 31 Mar 2020 10-Q 13 May 2020 2020 Q1
Q4 2019 $38,691,836 +$5,961,004 +18% 31 Dec 2019 10-K 30 Mar 2021 2020 FY
Q3 2019 $38,847,608 +$5,612,208 +17% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $39,409,398 +$6,668,186 +20% 30 Jun 2019 10-Q 12 Aug 2019 2019 Q2
Q1 2019 $40,476,630 +$6,844,531 +20% 31 Mar 2019 10-Q 13 May 2019 2019 Q1
Q4 2018 $32,730,832 -$1,568,124 -4.6% 31 Dec 2018 10-K 27 Mar 2020 2019 FY
Q3 2018 $33,235,400 +$2,945,586 +9.7% 30 Sep 2018 10-Q 13 Nov 2018 2018 Q3
Q2 2018 $32,741,212 +$4,679,673 +17% 30 Jun 2018 10-Q 13 Aug 2018 2018 Q2
Q1 2018 $33,632,099 +$8,298,471 +33% 31 Mar 2018 10-Q 14 May 2018 2018 Q1
Q4 2017 $34,298,956 +$9,601,775 +39% 31 Dec 2017 10-K 22 Mar 2019 2018 FY
Q3 2017 $30,289,814 +$9,711,370 +47% 30 Sep 2017 10-Q 13 Nov 2017 2017 Q3
Q2 2017 $28,061,539 +$7,487,196 +36% 30 Jun 2017 10-Q 14 Aug 2017 2017 Q2
Q1 2017 $25,333,628 +$4,951,605 +24% 31 Mar 2017 10-Q 11 May 2017 2017 Q1
Q4 2016 $24,697,181 +$10,156,914 +70% 31 Dec 2016 10-K 29 Mar 2018 2017 FY
Q3 2016 $20,578,444 +$6,355,298 +45% 30 Sep 2016 10-Q 10 Nov 2016 2016 Q3
Q2 2016 $20,574,343 +$9,331,990 +83% 30 Jun 2016 10-Q 11 Aug 2016 2016 Q2
Q1 2016 $20,382,023 +$9,152,315 +82% 31 Mar 2016 10-Q 11 May 2016 2016 Q1
Q4 2015 $14,540,267 +$3,488,413 +32% 31 Dec 2015 10-K 30 Mar 2017 2016 FY
Q3 2015 $14,223,146 +$3,482,177 +32% 30 Sep 2015 10-Q 12 Nov 2015 2015 Q3
Q2 2015 $11,242,353 +$474,548 +4.4% 30 Jun 2015 10-Q 13 Aug 2015 2015 Q2
Q1 2015 $11,229,708 +$113,911 +1% 31 Mar 2015 10-Q 12 May 2015 2015 Q1
Q4 2014 $11,051,854 +$91,140 +0.83% 31 Dec 2014 10-K 25 Mar 2016 2015 FY
Q3 2014 $10,740,969 -$324,718 -2.9% 30 Sep 2014 10-Q 12 Nov 2014 2014 Q3
Q2 2014 $10,767,805 -$607,014 -5.3% 30 Jun 2014 10-Q 13 Aug 2014 2014 Q2
Q1 2014 $11,115,797 +$4,310 +0.04% 31 Mar 2014 10-Q 14 May 2014 2014 Q1
Q4 2013 $10,960,714 -$69,693 -0.63% 31 Dec 2013 10-K 26 Mar 2015 2014 FY
Q3 2013 $11,065,687 +$94,708 +0.86% 30 Sep 2013 10-Q 13 Nov 2013 2013 Q3
Q2 2013 $11,374,819 +$337,790 +3.1% 30 Jun 2013 10-Q 13 Aug 2013 2013 Q2
Q1 2013 $11,111,487 -$59,477 -0.53% 31 Mar 2013 10-Q 14 May 2013 2013 Q1
Q4 2012 $11,030,407 +$39,135 +0.36% 31 Dec 2012 10-K 26 Mar 2014 2013 FY
Q3 2012 $10,970,979 -$7,695 -0.07% 30 Sep 2012 10-Q 13 Nov 2012 2012 Q3
Q2 2012 $11,037,029 -$251,621 -2.2% 30 Jun 2012 10-Q/A 07 Sep 2012 2012 Q2
Q1 2012 $11,170,964 31 Mar 2012 10-Q 14 May 2012 2012 Q1
Q4 2011 $10,991,272 +$240,093 +2.2% 31 Dec 2011 10-K 28 Mar 2013 2012 FY
Q3 2011 $10,978,674 30 Sep 2011 10-Q 14 Nov 2011 2011 Q3
Q2 2011 $11,288,650 30 Jun 2011 10-Q 15 Aug 2011 2011 Q2
Q4 2010 $10,751,179 31 Dec 2010 10-K 27 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.